What is the recommended intravenous cefuroxime dose for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intravenous Cefuroxime Pediatric Dosing

For most pediatric infections in children >3 months of age, administer cefuroxime 50-100 mg/kg/day IV divided every 6-8 hours, with higher doses (100 mg/kg/day) reserved for severe infections. 1

Standard Dosing by Age and Indication

Infants and Children >3 Months of Age

  • Most infections (mild to moderate): 50-100 mg/kg/day divided every 6-8 hours IV 1
  • Severe or serious infections: 100 mg/kg/day (not to exceed maximum adult dosage) divided every 6-8 hours 1
  • Bone and joint infections: 150 mg/kg/day (not to exceed maximum adult dosage) divided every 8 hours 1, 2
  • Bacterial meningitis: 200-240 mg/kg/day IV divided every 6-8 hours 1, 3, 4

Neonates and Infants <3 Months

The FDA label does not provide specific dosing recommendations for infants <3 months of age 1. Alternative antibiotics should be considered for this age group.

Specific Clinical Applications

Community-Acquired Pneumonia

For Streptococcus pneumoniae with penicillin MIC <2.0 µg/mL, cefuroxime can be used as an alternative oral step-down therapy (not as primary parenteral therapy, where ceftriaxone or cefotaxime are preferred) 2. The typical IV dose when used is 150 mg/kg/day divided every 6-8 hours 2.

Intra-Abdominal Infections

Administer 150 mg/kg/day divided every 6-8 hours for complicated intra-abdominal infections 2.

Skin and Skin Structure Infections

Use 50-100 mg/kg/day divided every 6 or 8 hours IV, with clinical studies demonstrating efficacy at doses up to 300 mg/kg/day 5.

Renal Impairment Adjustments

In pediatric patients with renal insufficiency, modify the frequency of dosing consistent with adult recommendations 1:

  • CrCl >20 mL/min: Standard dosing every 8 hours
  • CrCl 10-20 mL/min: Reduce frequency to every 12 hours
  • CrCl <10 mL/min: Reduce frequency to every 24 hours

Administration Guidelines

Preparation

  • IV bolus: Reconstitute 750 mg vial with 8.3 mL sterile water (90 mg/mL concentration) 1
  • IM injection: Reconstitute 750 mg vial with 3 mL sterile water (225 mg/mL suspension) 1

Infusion Technique

  • Direct IV: Inject slowly over 3-5 minutes 1
  • Intermittent infusion: Can be given through Y-type administration set 1
  • Continuous infusion: May be added to compatible IV fluids (0.9% NaCl, 5% dextrose, etc.) 1

Important Clinical Considerations

Duration of Therapy

Continue treatment for a minimum of 48-72 hours after the patient becomes asymptomatic or after bacterial eradication is documented 1. For Streptococcus pyogenes infections, treat for a minimum of 10 days to prevent rheumatic fever or glomerulonephritis 1.

Pharmacokinetic Data

In pediatric patients, cefuroxime achieves therapeutic CSF concentrations during meningitis treatment, with mean levels of 6.6 µg/mL (range 0.9-17.3) in children receiving 200 mg/kg/day divided every 6 hours 2. Peak serum concentrations after 25 mg/kg IV infusion average 29.1 µg/mL at 30 minutes 6.

Common Pitfalls to Avoid

  • Do not underdose severe infections: Use the full 100 mg/kg/day for serious infections rather than the lower 50 mg/kg/day dose 1
  • Do not use for neonates <3 months: Safety and efficacy not established in this age group 1
  • Do not mix with aminoglycosides: Potential interaction exists; administer separately 1
  • Adjust for renal dysfunction: Failure to reduce dosing frequency in renal impairment can lead to drug accumulation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.